A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod

- Relapsing Remitting Multiple Sclerosis
- Completed

Study Title: A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod

Teva Identifier: LAQ/5062 | 2004-003943-28

ClinicalTrials.gov Identifier: NCT00349193

Study Status: Completed

Trial Condition(s): Relapsing Remitting Multiple Sclerosis

Interventions: Drug: laquinimod 0.3 | Drug: laquinimod 0.6 | Other: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age Range: 18 Years to 50 Years

Trial Duration: 03/01/2005 - 08/01/2006

Phase: Phase 2

Study Type

Interventional